Exploration of M2 macrophage membrane as a biotherapeutic agent and strong synergistic therapeutic effects in ischemic stroke
Journal of Controlled Release · 2025-02 · 378 · 476-489
DOI: 10.1016/j.jconrel.2024.11.033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2025-02. Verfasst von Shanshan Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. Hauptthemen laut MEDLINE: Ischemic Stroke, Macrophages, Flavonoids. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China.
Themen: Schlaganfall
Abstract (Originalsprache)
The macrophage-derived membrane is widely applied in the targeting nanocarrier for its inflammatory tendency and long circulation ability due to the preservation of membrane protein. Few studies reported the application of macrophage membranes as biotherapeutic agents. To verify the ability of macrophage membrane as a biotherapeutic agent, ischemic stroke was selected as the model disease. Inspired by the features of macrophages infiltrating the ischemic core and the talent of M2 macrophages in modulating the inflammatory microenvironment, an M2 macrophage membrane (M2M)-disguised poly lactic-co-glycolic acid nanoparticles loaded with baicalin (BA) (M2M@BANPs) is developed. The results in vivo and in vitro indicate that M2M@BANPs could efficiently and actively target ischemic brain tissue and accumulate in microglia and neurons due to the coating of M2M. Furthermore, M2M and M2M@BANPs exhibit significant therapeutic effects in salvaging brain tissue damage and neurological functional recovery by reprogramming microglia from M1 to M2, reducing neutrophil infiltration and inhibiting neuronal apoptosis. Together, our fabrication provides a new insight and an applicative perspective for M2M in the therapy of ischemic stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
- School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. Electronic address: fanxiang_78@hotmail.com.
Förderung
- Natural Science Foundation of Zhejiang Province
- National Natural Science Foundation of China
Zitieren
APA
Zhang, S., Li, R., Song, M., Han, J., & Fan, X. (2025). Exploration of M2 macrophage membrane as a biotherapeutic agent and strong synergistic therapeutic effects in ischemic stroke. Journal of Controlled Release, 378, 476-489. https://doi.org/10.1016/j.jconrel.2024.11.033
Vancouver
Zhang S, Li R, Song M, Han J, Fan X. Exploration of M2 macrophage membrane as a biotherapeutic agent and strong synergistic therapeutic effects in ischemic stroke. Journal of Controlled Release. 2025;378:476-489. doi:10.1016/j.jconrel.2024.11.033
BibTeX
@article{Zhang2025,
author = {Zhang, Shanshan and Li, Ruoqi and Song, Meiying and Han, Jin and Fan, Xiang},
title = {Exploration of M2 macrophage membrane as a biotherapeutic agent and strong synergistic therapeutic effects in ischemic stroke},
journal = {Journal of Controlled Release},
year = {2025},
volume = {378},
pages = {476--489},
doi = {10.1016/j.jconrel.2024.11.033}
}
EUVIMED